Brain chemical targeted to help autistic teens connect
NCT ID NCT05063656
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 30 times
Summary
This study tested a medicine called gabapentin in 16 teenagers (ages 13-17) with autism. The goal was to see if it could raise a brain chemical called GABA, which may help with social thinking and interaction. Researchers used brain scans to measure changes and check if the treatment worked.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Massachusetts Medical School
Worcester, Massachusetts, 01655, United States
Conditions
Explore the condition pages connected to this study.